Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Short-Term Debt repayments (2016 - 2022)

Prestige Consumer Healthcare has reported Short-Term Debt repayments over the past 11 years, most recently at $10.0 million for Q3 2022.

  • Quarterly results put Short-Term Debt repayments at $10.0 million for Q3 2022, down 84.62% from a year ago — trailing twelve months through Jun 2023 was $10.0 million (down 89.47% YoY), and the annual figure for FY2023 was $20.0 million, down 76.47%.
  • Short-Term Debt repayments for Q3 2022 was $10.0 million at Prestige Consumer Healthcare, roughly flat from $10.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for PBH hit a ceiling of $65.0 million in Q3 2021 and a floor of $5.0 million in Q1 2018.
  • Median Short-Term Debt repayments over the past 5 years was $20.0 million (2018), compared with a mean of $26.5 million.
  • Biggest five-year swings in Short-Term Debt repayments: surged 310.0% in 2019 and later crashed 84.62% in 2022.
  • Prestige Consumer Healthcare's Short-Term Debt repayments stood at $15.0 million in 2018, then skyrocketed by 193.33% to $44.0 million in 2019, then crashed by 65.91% to $15.0 million in 2020, then soared by 33.33% to $20.0 million in 2021, then crashed by 50.0% to $10.0 million in 2022.
  • The last three reported values for Short-Term Debt repayments were $10.0 million (Q3 2022), $10.0 million (Q2 2022), and $20.0 million (Q4 2021) per Business Quant data.